F Clarençon1, F Di Maria2, J Gabrieli2, E Shotar2, C Zeghal3, A Nouet4, J Chiras2, N-A Sourour2. 1. Department of Interventional Neuroradiology, Pitié-Salpêtrière Hospital, Pierre et Marie Curie University, 47, Bd de l'Hôpital, 75013, Paris, France. fredclare5@msn.com. 2. Department of Interventional Neuroradiology, Pitié-Salpêtrière Hospital, Pierre et Marie Curie University, 47, Bd de l'Hôpital, 75013, Paris, France. 3. Department of Anesthesiology, Pitié-Salpêtrière Hospital, Pierre et Marie Curie University, Paris, France. 4. Department of Neurosurgery, Pitié-Salpêtrière Hospital, Pierre et Marie Curie University, Paris, France.
Abstract
BACKGROUND AND PURPOSE: Flow diverter stents (FDSs) are increasingly used for the treatment of intracranial aneurysms. Initially developed for the management of giant and large aneurysms, their indications have progressively expanded. The purpose of our study was to evaluate the safety and effectiveness of FDSs for the treatment of anterior cerebral artery (ACA) aneurysms. MATERIALS AND METHODS: Among the 94 consecutive patients treated for 100 intracranial aneurysms by means of FDSs in our institution from October 2010 to January 2015, eight aneurysms (8 %) in seven patients were located on the ACA. Three aneurysms were located on the A1 segment, three aneurysms on the anterior communicating artery (ACom) and two on the A2-A3 junction. In three cases, FDS was used for angiographic recurrence after coiling. Five patients were treated with a Pipeline embolization device, one with a NeuroEndograft and the last one with a Silk FDS. RESULTS: Treatment was feasible in all cases. No technical difficulty was reported. No acute or delayed clinical complication was recorded. Modified Rankin Scale was 0 for six patients and one for one patient. Mean angiographic follow-up was 9.7 ± 3.9 months (range 6-15). Total exclusion was observed in five aneurysms (71.4 %) and neck remnant in two (28.6 %) cases. One patient refused the control DSA. CONCLUSION: Our series shows the safety and effectiveness of FDSs for the treatment of ACA aneurysms.
BACKGROUND AND PURPOSE: Flow diverter stents (FDSs) are increasingly used for the treatment of intracranial aneurysms. Initially developed for the management of giant and large aneurysms, their indications have progressively expanded. The purpose of our study was to evaluate the safety and effectiveness of FDSs for the treatment of anterior cerebral artery (ACA) aneurysms. MATERIALS AND METHODS: Among the 94 consecutive patients treated for 100 intracranial aneurysms by means of FDSs in our institution from October 2010 to January 2015, eight aneurysms (8 %) in seven patients were located on the ACA. Three aneurysms were located on the A1 segment, three aneurysms on the anterior communicating artery (ACom) and two on the A2-A3 junction. In three cases, FDS was used for angiographic recurrence after coiling. Five patients were treated with a Pipeline embolization device, one with a NeuroEndograft and the last one with a Silk FDS. RESULTS: Treatment was feasible in all cases. No technical difficulty was reported. No acute or delayed clinical complication was recorded. Modified Rankin Scale was 0 for six patients and one for one patient. Mean angiographic follow-up was 9.7 ± 3.9 months (range 6-15). Total exclusion was observed in five aneurysms (71.4 %) and neck remnant in two (28.6 %) cases. One patient refused the control DSA. CONCLUSION: Our series shows the safety and effectiveness of FDSs for the treatment of ACA aneurysms.
Authors: C N Ionita; S K Natarajan; W Wang; L N Hopkins; E I Levy; A H Siddiqui; D R Bednarek; S Rudin Journal: AJNR Am J Neuroradiol Date: 2011-07-14 Impact factor: 3.825
Authors: E Tollard; L Niemtschik; T E Darsaut; F Guilbert; D Roy; J Raymond; A Weill Journal: AJNR Am J Neuroradiol Date: 2010-09-02 Impact factor: 3.825
Authors: Nohra Chalouhi; Robert M Starke; Steven Yang; Cory D Bovenzi; Stavropoula Tjoumakaris; David Hasan; L Fernando Gonzalez; Robert Rosenwasser; Pascal Jabbour Journal: Stroke Date: 2013-11-19 Impact factor: 7.914
Authors: F Diana; A Pesce; G Toccaceli; V Muralidharan; E Raz; M Miscusi; A Raco; P Missori; S Peschillo Journal: Neurosurg Rev Date: 2021-10-07 Impact factor: 3.042
Authors: Ajit S Puri; Francesco Massari; Takumi Asai; Miklos Marosfoi; Peter Kan; Samuel Y Hou; Mary Howk; Mary Perras; Christopher Brooks; Frederic Clarencon; Matthew J Gounis; Ajay K Wakhloo Journal: Neuroradiology Date: 2015-12-23 Impact factor: 2.804
Authors: P Bhogal; R Martinez Moreno; O Ganslandt; H Bäzner; H Henkes; M Aguilar Perez Journal: J Neurointerv Surg Date: 2016-10-27 Impact factor: 5.836